Welcome to LookChem.com Sign In|Join Free
  • or
2,4-Thiazolidinedione, 5-[[4-[2-(4-oxo-2H-1,3-benzoxazin-3(4H)-yl)ethoxy]phenyl]methyl]is a compound that belongs to the thiazolidinedione class of drugs, which are primarily used in the treatment of type 2 diabetes. This specific compound is a derivative of thiazolidinedione and features a benzoxazin-3-one moiety. It is likely to possess antidiabetic and potentially anti-inflammatory properties, owing to its structural resemblance to other thiazolidinedione compounds. 2,4-Thiazolidinedione,
5-[[4-[2-(4-oxo-2H-1,3-benzoxazin-3(4H)-yl)ethoxy]phenyl]methyl]may function by enhancing insulin sensitivity and decreasing glucose levels in the body, presenting a potential new therapeutic option for diabetes management. Further research is essential to comprehensively understand its pharmacological characteristics and possible applications.

194713-46-7

Post Buying Request

194713-46-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

194713-46-7 Usage

Uses

Used in Pharmaceutical Industry:
2,4-Thiazolidinedione, 5-[[4-[2-(4-oxo-2H-1,3-benzoxazin-3(4H)-yl)ethoxy]phenyl]methyl]is used as a potential antidiabetic agent for the treatment of type 2 diabetes. Its application is based on the compound's ability to improve insulin sensitivity and reduce glucose levels in the body, offering a new approach to managing diabetes.
Used in Research and Development:
In the field of pharmaceutical research and development, 2,4-Thiazolidinedione, 5-[[4-[2-(4-oxo-2H-1,3-benzoxazin-3(4H)-yl)ethoxy]phenyl]methyl]is used as a subject for further investigation to understand its pharmacological properties, potential side effects, and therapeutic efficacy. This research is crucial for determining its viability as a new treatment option for diabetes and possibly other conditions related to insulin resistance or inflammation.

Check Digit Verification of cas no

The CAS Registry Mumber 194713-46-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,4,7,1 and 3 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 194713-46:
(8*1)+(7*9)+(6*4)+(5*7)+(4*1)+(3*3)+(2*4)+(1*6)=157
157 % 10 = 7
So 194713-46-7 is a valid CAS Registry Number.

194713-46-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-{4-[2-(4-oxo-3,4-dihydro-2H- 1,3-benzoxazin-3-yl)ethoxy]benzyl}-2,4-thiazolidinedione

1.2 Other means of identification

Product number -
Other names 5-[4-[2-(4-oxo-3,4-dihydro-2H-1,3-benzoxazin-3-yl)ethoxy]benzyl]-2,4-thiazolidinedione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:194713-46-7 SDS

194713-46-7Downstream Products

194713-46-7Relevant academic research and scientific papers

Dual PPAR-α and -γ activators derived from novel benzoxazinone containing thiazolidinediones having antidiabetic and hypolipidemic potential

Madhavan, Gurram R.,Chakrabarti, Ranjan,Anantha Reddy,Rajesh,Balraju,Bheema Rao,Rajagopalan,Iqbal, Javed

, p. 584 - 591 (2007/10/03)

2,4-Thiazolidinedione derivatives of 1,3-benzoxazinone were synthesized and evaluated for their PPAR-α and -γ dual activation. DRF-2519, a compound obtained through SAR of TZD derivatives of benzoxazinone, has shown potent dual PPAR activation. In ob/ob mice, it showed better efficacy than the comparator molecules. In fat fed rat model, it showed significant improvement in lipid parameters, which was better than fibrates.

Benzoazine derivative or salt thereof and pharmaceutical compostion comprising the same

-

, (2008/06/13)

A benzoazine derivative represented by the following formula (1), STR1 wherein R1 represents an alkyl group, alkoxy group, halogen atom, halogenoalkyl group, amino group, hydroxy group, benzyloxy group which may have a substituent, cyano group,

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 194713-46-7